SpringerLink
Log in

Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

To assess the effectiveness of early salvage radiotherapy (RT) for patients with prostate-specific antigen (PSA) relapse after radical prostatectomy (RP) retrospectively.

Methods

Fifty-one patients underwent salvage RT for biochemical relapse of prostate cancer initially treated with RP. All patients had persistent or rising PSA >0.20 ng/ml at some point after surgery, or three successive PSA elevations after a postoperative nadir if PSA was ≤0.20 ng/ml. Most (96%) of pre-RT PSA were less or equal to 0.50 ng/ml, and median value was 0.25 ng/ml (range, 0.05–0.90 ng/ml). Median RT dose was 60 Gy (range, 50–66 Gy). Multivariate Cox regression analysis was performed for PSA before RP and salvage RT, margin status, seminal vesicle involvement, extracapsular invasion, Gleason score, PSA doubling time (PSADT), and RT dose to identify significant predictors of biochemical outcome.

Results

Median follow-up was 36 months. The 3-year biochemical no evidence of disease rate (bNED) was 55.1%. On multivariate analysis only the following factors were significantly associated with improved bNED: PSADT >3.0 months (P = 0.008), Gleason score ≤7 (P = 0.01), and RT dose ≥60 Gy (P = 0.028).

Conclusions

Although a total dose of 60 Gy was effective at a low pre-RT PSA levels with short follow-up, an RT dose ≥60 Gy resulted in superior biochemical outcomes even in patients with a pre-RT PSA ≤0.50 ng/ml.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Anscher MS, Clough R, Dodge R (2000) Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. Int J Radiat Oncol Biol Phys 48:369–375. doi:10.1016/S0360-3016(00)00645-3

    PubMed  CAS  Google Scholar 

  • Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, Collie AC, Ferrigni RG, Myers RP, Prussak KA, Heckman MG, Crook JE, Parker AS, Igel TC (2006) Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. J Urol 176:985–990. doi:10.1016/j.juro.2006.04.083

    Article  PubMed  Google Scholar 

  • Catton C, Gospodarowicz M, Warde P, Panzarella T, Catton P, McLean M, Milosevic M (2001) Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol 59:51–60

    Google Scholar 

  • Chawla AK, Thakral HK, Zietman AL, Shipley WU (2002) Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors. Urology 59:726–731. doi:10.1016/S0090-4295(02)01540-6

    Article  PubMed  Google Scholar 

  • Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D’Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540–545. doi:10.1016/j.juro.2006.10.097

    Article  PubMed  CAS  Google Scholar 

  • Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346. doi:10.1016/0360-3016(95)00060-C

    PubMed  CAS  Google Scholar 

  • Cox JD, Gallagher MJ, Hammond EH, Kaplan RS, Schellhammer PF (1999) Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel. J Clin Oncol 17:1155

    PubMed  CAS  Google Scholar 

  • De Meerleer G, Fonteyne V, Meersschout S, Van den Broecke C, Villeirs G, Lumen N, Ost P, Vandecasteele K, De Neve W (2008) Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy. Radiother Oncol 89:205–213. doi:10.1016/j.radonc.2008.07.027

    Article  PubMed  Google Scholar 

  • Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169:517–523. doi:10.1016/S0022-5347(05)63946-8

    Article  PubMed  Google Scholar 

  • Kalapurakal JA, Huang CF, Neriamparampil MM, Small WJ Jr, Pins MR, Mittal BB, Campbell SC, Grayhack JT, Shetty RM (2002) Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy. Int J Radiat Oncol Biol Phys 54:1047–1054. doi:10.1016/S0360-3016(02)03034-1

    Article  PubMed  Google Scholar 

  • King CR, Spiotto MT (2008) Improved outcomes with higher doses for salvage radiotherapy after prostatectomy. Int J Radiat Oncol Biol Phys 71:23–27. doi:10.1016/j.ijrobp.2007.09.047

    PubMed  Google Scholar 

  • Leventis AK, Shariat SF, Kattan MW, Butler EB, Wheeler TM, Slawin KM (2001) Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 19:1030–1039

    PubMed  CAS  Google Scholar 

  • Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW (2003) Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol 170:1833–1837. doi:10.1097/01.ju.0000091835.80547.a4

    Article  PubMed  Google Scholar 

  • Parker C, Warde P, Catton C (2001) Salvage radiotherapy for PSA failure after radical prostatectomy. Radiother Oncol 61:107–116. doi:10.1016/S0167-8140(01)00439-X

    Article  PubMed  CAS  Google Scholar 

  • Pasquier D, Ballereau C (2008) Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review. Int J Radiat Oncol Biol Phys 72:972–979. doi:10.1016/j.ijrobp.2008.07.026

    PubMed  Google Scholar 

  • Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591–1597. doi:10.1001/jama.281.17.1591

    Article  PubMed  CAS  Google Scholar 

  • Quero L, Mongiat-Artus P, Ravery V, Maylin C, Desgrandchamps F, Hennequin C (2008) Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience. BMC Cancer 8:26. doi:10.1186/1471-2407-8-26

    Article  PubMed  Google Scholar 

  • Sidhom MA, Kneebone AB, Lehman M, Wiltshire KL, Millar JL, Mukherjee RK, Shakespeare TP, Tai KH (2008) Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group. Radiother Oncol 88:10–19. doi:10.1016/j.radonc.2008.05.006

    Article  PubMed  Google Scholar 

  • Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr, Lilja H, Scardino PT (2006) Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24:3973–3978. doi:10.1200/JCO.2005.04.0756

    Article  PubMed  CAS  Google Scholar 

  • Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A (2007) Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25:2035–2041. doi:10.1200/JCO.2006.08.9607

    Article  PubMed  Google Scholar 

  • Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A (2003) Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 56:755–763. doi:10.1016/S0360-3016(03)00069-5

    PubMed  CAS  Google Scholar 

  • Tomita N, Kodaira T, Tachibana H, Nakamura T, Tomoda T, Nakahara R, Inokuchi H, Hayashi N, Fuwa N (2009) Preliminary results of dynamic conformal arc radiotherapy with rectum hollow-out technique for localized prostate cancer. Radiother Oncol 90:346–352. doi:10.1016/j.radonc.2008.09.020

    Article  PubMed  Google Scholar 

  • Valicenti RK, Gomella LG, Ismail M, Mulholland SG, Petersen RO, Corn BW (1998) Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 42:501–506. doi:10.1016/S0360-3016(98)00270-3

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusaku, Nagoya, 464-8681, Japan

    Natsuo Tomita, Takeshi Kodaira, Kazuhisa Furutani, Hiroyuki Tachibana, Rie Nakahara & Nobutaka Mizoguchi

  2. Department of Urology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusaku, Nagoya, 464-8681, Japan

    Norio Hayashi

Authors
  1. Natsuo Tomita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takeshi Kodaira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuhisa Furutani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroyuki Tachibana
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rie Nakahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nobutaka Mizoguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Norio Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Natsuo Tomita.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomita, N., Kodaira, T., Furutani, K. et al. Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy. J Cancer Res Clin Oncol 135, 1561–1567 (2009). https://doi.org/10.1007/s00432-009-0603-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-009-0603-7

Keywords

Search

Navigation